Recombinant Human KAT2B Protein，His

KAT2B, also known as GCN5, is a member of the MYST family of histone acetyltransferases, playing a crucial role in the regulation of gene expression through histone acetylation. This protein is involved in various cellular processes, including transcriptional activation, DNA repair, and cell cycle progression. Dysregulation of KAT2B has been implicated in numerous diseases, including cancer and neurodegenerative disorders, making it a significant target for therapeutic intervention. Recent research has focused on the structural and functional characterization of KAT2B, along with the identification of its substrates and interacting partners. Recombinant KAT2B proteins are essential for these studies, providing valuable insights into the enzyme's mechanisms and potential roles in disease. By producing KAT2B in a recombinant form, researchers can investigate its enzymatic activity, explore protein-protein interactions, and assess the effects of small molecules or inhibitors on its function. This research is vital for understanding how KAT2B contributes to cellular homeostasis and for developing novel strategies to modulate its activity in pathological conditions. As the field progresses, the elucidation of KAT2B's role in epigenetic regulation and its therapeutic potential continues to attract significant attention, highlighting the importance of recombinant protein research in unraveling the complexities of gene regulation.